J&J COVID-19 vaccine - The African Mirror

Aug

2022

South Africa reports first death causally linked to COVID vaccine

SOUTH Africa's health regulator reported a causal link between the death of an individual and Johnson & Johnson's (J&J) COVID-19 vaccine, the first time such a direct link has been made in the country. The person presented with rare neurological disorder Guillain-Barre Syndrome soon after being given J&J's Janssen vaccine, after which the person was put on a ventilator and later died, senior scientists told a news conference. "At the time of illness no other cause for the Guillain-Barre Syndrome (GBS) could be identified," Professor Hannelie Meyer said. The person's age and other personal details were not disclosed for confidentiality reasons.…

Jul

2021

By The African Mirror

Zim approves J&J vaccine for use

COVID-19

ZIMBABWE has authorised the emergency use of Johnson & Johnson's COVID-19 vaccine, the first Western-made shot to be approved by the southern African nation, its medicines regulator said has announced. Like many African countries, Zimbabwe is in the grips of a third wave of infections, with nearly half of its 101,711 cumulative cases and 3,280 deaths recorded this month alone, according to official data. Until now, the Medicines Control Authority of Zimbabwe (MCAZ) had only registered vaccines from India, Russia and China. "MCAZ reviewed the technical documentation that was submitted by the manufacturer, and emergency use authorisation was granted and…

Jan

2021

By The African Mirror

J&J COVID-19 vaccine on track for rollout

COVID-19

JULIE STEENHYSEN JOHNSON&JOHNSON is on track to roll out its single-shot coronavirus vaccine in March, and plans to have clear data on how effective it is by the end of this month or early February, the U.S. healthcare company's chief science officer said. Dr. Paul Stoffels in an interview also said J&J expects to meet its stated target of delivering one billion doses of its vaccine by the end of this year as the company ramps up production. The New York Times has reported that J&J was experiencing manufacturing delays that would reduce the number of doses initially available. Stoffels…